Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43M Sell
365,115
-130,435
-26% -$18.2M 0.82% 41
2025
Q4
$81.2M Sell
495,550
-39,169
-7% -$6.13M 1.17% 30
2025
Q3
$71.5M Sell
534,719
-51,754
-9% -$6.29M 0.92% 35
2025
Q2
$72.9M Buy
586,473
+11,797
+2% +$1.5M 0.93% 37
2025
Q1
$73.1M Buy
574,676
+11,396
+2% +$1.75M 0.98% 34
2024
Q4
$81.1M Sell
563,280
-27,041
-5% -$3.88M 1.03% 34
2024
Q3
$87.9M Buy
590,321
+139,615
+31% +$20M 1.07% 32
2024
Q2
$56.8M Buy
450,706
+10,828
+2% +$1.7M 0.73% 42
2024
Q1
$80.9M Sell
439,878
-46,475
-10% -$8.85M 0.99% 34
2023
Q4
$87.4M Buy
486,353
+104,860
+27% +$16.3M 1.16% 30
2023
Q3
$60.7M Sell
381,493
-3,583
-0.9% -$586K 0.89% 38
2023
Q2
$54.5M Buy
385,076
+297,064
+338% +$47.6M 0.74% 42
2023
Q1
$14.8M Buy
88,012
+7,103
+9% +$1.27M 0.21% 66
2022
Q4
$13.7M Sell
80,909
-2,814
-3% -$510K 0.2% 64
2022
Q3
$15.7M Sell
83,723
-13,356
-14% -$2.82M 0.24% 62
2022
Q2
$15.8M Buy
97,079
+7,711
+9% +$1.22M 0.22% 62
2022
Q1
$16.8M Buy
89,368
+28,059
+46% +$5.33M 0.19% 67
2021
Q4
$16.2M Sell
61,309
-492
-0.8% -$133K 0.16% 77
2021
Q3
$17.9M Buy
61,801
+4,075
+7% +$1.05M 0.18% 67
2021
Q2
$11.5M Buy
57,726
+3,703
+7% +$718K 0.12% 79
2021
Q1
$10.5M Buy
54,023
+4,058
+8% +$832K 0.12% 77
2020
Q4
$9.57M Buy
49,965
+4,353
+10% +$792K 0.11% 74
2020
Q3
$6.73M Buy
45,612
+1,312
+3% +$188K 0.09% 76
2020
Q2
$5.48M Buy
44,300
+16,452
+59% +$1.94M 0.08% 76
2020
Q1
$2.69M Buy
+27,848
New +$2.69M 0.05% 92

Other funds holding RGEN

DF Dent & Co's RGEN Position: Q1 2026 in Review

DF Dent & Co reduced its Repligen (RGEN) stake by 26% in Q1 2026, selling an estimated $18.2M and leaving 365,115 shares worth $43M. The position accounts for 0.82% of the portfolio, ranked #41.

DF Dent & Co first reported a position in RGEN in Q1 2020 and has held it in 25 quarters since. The position peaked at $87.9M in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • DF Dent & Co held 365,115 shares of Repligen worth $43M as of Q1 2026.
  • DF Dent & Co sold 130,435 Repligen shares in Q1 2026, an estimated $18.2M.
  • Repligen made up 0.82% of DF Dent & Co's portfolio in Q1 2026, its #41 holding.
  • DF Dent & Co first reported a position in Repligen in Q1 2020 and has held it in 25 quarters since.
  • DF Dent & Co's Repligen position peaked at $87.9M in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on DF Dent & Co's 13F filing for Q1 2026, filed 15 May 2026.